key: cord-0830144-3cr5x88g
authors: Zheng, Zhong; Yao, Zhixian; Wu, Ke; Zheng, Junhua
title: Patient Follow‐up after Discharge after COVID‐19 Pneumonia: Considerations for Infectious Control
date: 2020-05-08
journal: J Med Virol
DOI: 10.1002/jmv.25994
sha: 436d6c2fe581a22038cf304e5bccc44082eaf6dd
doc_id: 830144
cord_uid: 3cr5x88g

Coronavirus disease 2019 (COVID‐19) represents a significant global medical issue, with a growing number of cumulative confirmed cases. However, a large number of COVID‐19 patients have overcome the disease, meeting hospital discharge criteria, and are gradually returning to work and social life. Nonetheless, COVID‐19 may cause further downstream issues in these patients, such as due to possible reactivation of the virus, long‐term pulmonary defects, and post‐traumatic stress disorder. In this study, we therefore queried relevant literature concerning SARS, MERS, and COVID‐19 for reference to come to a consensus on follow‐up strategies. We found that strategies such as implementation of PCR testing, imaging surveillance, and psychological assessments, starting at the time of discharge, were necessary for long‐term follow‐up. If close care is given to every aspect of coronavirus management, we expect that the pandemic outbreak will soon be overcome. This article is protected by copyright. All rights reserved.

At the end of 2019, a novel coronavirus (SARS-CoV-2) emerged in Wuhan, China, and caused the outbreak of 2019 coronavirus disease (COVID-19) 1 2 . Since the index patient was hospitalized on December 12, 2019, SARS-CoV-2 has rapidly spread around the globe 3 . As of May 6, 2020, 3,588,773 cases have been confirmed worldwide, and 247,503 patients have died 4 . Molecular analysis indicates that SARS-CoV-2 most likely originated from bats after passage in intermediate hosts, which highlights the high zoonotic potential of coronaviruses 5 . Similar to the Severe Acute Respiratory Syndrome (SARS) and the Middle East respiratory syndrome coronavirus (MERS), COVID-19 has so far been treated with a variety of therapeutic strategies, such as antiviral therapies, glucocorticoids, pulmonary supportive therapy, traditional Chinese medicine, and immunotherapy [6] [7] [8] [9] [10] [11] [12] [13] . Notably, when patients advance into acute respiratory distress syndrome, glucocorticoid therapy has been shown to exert a significant curative effect due to repression of the cytokine storm 12 14 .

Currently, the WHO reports a COVID-19 mortality rate of 4.4%, compared with 9.6% for SARS and 34.4% for MERS, which indicates that this new viral disease is not as fatal as initially anticipated 4 15 . However, even after symptoms have been alleviated in patients after treatment, relapse of COVID-19 still represents a considerable risk 16 . As mentioned above, corticosteroid therapy might be an option to manage severe pneumonia, however, tapering off the corticosteroid dose could lead to recurrence 17 . Similarly, even when patients reached apparent recovery, viral load occasionally remains at high levels, meaning that these patients could still act as virus carriers 18 .

Thus, a clear definition of discharge criteria and follow-up strategies is critical for global management of this pandemic. We searched the literature in Pubmed, Web of Science, and the

Cochrane Library, and summarize the findings concerning the standard of discharge and follow-up of SARS, MERS, and COVID-19 for the consideration of clinicians in this report. (Table.1) At present, in China, there are 73,159 cumulative cured, with only 4,735 confirmed hospitalized cases 19 .

We found the following discharge criteria for COVID-19: the blood oxygen saturation of the patient should have returned to normal levels without a need for oxygen support, a normal body temperature for more than three days, negative PCR tests on two consecutive occasions with a sampling interval of at least a day, and a chest CT (Computed Tomography) showing that the lesion is essentially absorbed, or only a few fibrous stripes can be observed 20 . Some researchers recommended that the body temperature should be at normal levels for more than a week before discharge 16 . The assessments before discharge were the following: CT lesions, which were mainly ground-glass opacities (GGOs), should have decreased in size and consolidations, if present, should have decreased in density. The viral load in stool and urine should be tested using real-time RT-PCR (real time reverse transcription-polymerase chain reaction, rRT-PCR) if possible [21] [22] [23] [24] . We found the following clinical feature descriptions for discharge: leukocytes and lymphocytes were increased in routine blood analysis, indicating recovery and restoration of immune function, the ear temperature was below 37.5℃, blood oxygen saturation was higher than 93% without supplementary oxygen, and the general health was discussed and evaluated by a multidisciplinary team of experts in hospital 6 25 .

For SARS, a viral disease derived from Paguma larvata and originating Guangdong, China, the discharge criteria were determined as an afebrile condition for four consecutive days, improvement of previously abnormal blood analysis, radiographic improvement, and a period of at least 21 days following the onset of illness, though it has been shown that the SARS coronavirus may still be detectable in the stool of recovered patients for up to 3 weeks 12 .

Moreover, some clinicians suggested that the chest consolidation should have reduced by 25%

for discharge, the patient should not require supplementary oxygen. Clinicians advised discharged patients to stay home for one week with a facemask, and as coronavirus might be shed in feces, emphasized toilet hygiene 26 . Guidelines from the World Health Organization indicated that an afebrile condition for 48 hours (or, more conservatively, 72 hours in Singapore) might be a sufficient discharge criteria 27 28 . No consecutive PCR testing was mentioned.

MERS, originating in the Middle East and transmitted from camels, was more severe than COVID-19 and SARS, predominantly due to induction of life-threatening injuries such as renal failure and septic shock 13 . The discharge criteria for MERS patients were not precisely clear, which might due to flexible policies in different hospitals. Testing for viral shedding was recommended to assist decision-making when readily available, and repeat testing should be carried out 24 and 48 hours after resolution of symptoms. If two repeated PCR tests were negative, discontinuation of isolation and droplet precautions of MERS might be considered after discussion with an Infectious Disease Physician 29 . Another study recommended that the interval between the two consecutive negative PCR tests should be more than 48 hours 30 . As for the guidelines in China, studies have suggested that the PCR testing interval should be between 2 to 4 days, with essentially normal body temperature and improved clinical symptoms 31 .

Discharge should not be considered as the final point of overcoming coronavirus, and the disease should not be taken lightly even after discharge, not only by patients as well as close contacts but also clinicians, radiologists, and psychologists.

Previous studies have demonstrated that asymptomatic and mildly symptomatic case patients can test PCR-positive >2 weeks from lower respiratory tract specimens 18 . Approximately 3.2-9.1% of patients discharged from the hospital might experience reactivation of SARS-CoV-2however, without specific clinical characteristics to distinguish it 32 33 . Patients with previously negative rRT-PCR have been occasionally shown to test positive again 4 to 17 days after discharge, potentially due to factors such as sex, older age, glucocorticoid therapy, high baseline SARS-CoV-2 load, variable genotypes, or related to re-infection or secondary bacterial or viral infection 16 32 33 .

These findings suggest that at least a proportion of recovered patients may still be viral carriers 18 . Hepatitis C virus is exceptionally susceptible to mutation, and the immune protection of the human body cannot keep up with the rate of mutation, meaning that after mutation, the original immunity cannot stave off the mutated virus, and re-infection will occur 34 . Interestingly, this does not seem to be the case for SARS-CoV-2. Genomes of 104 strains SARS-CoV-2 isolated from different locations subjected to whole gene sequencing showed a 99.9% homology, with no evidence for SARS-CoV-2 mutation 16 . Furthermore, the diagnosis rate of rRT-PCR has been shown to be about approximately 50~97% [72 ± 15 (mean ± SD)] 35-38 , which indicates that there could be a large number of discharged patients shedding the virus from stool or urine for longer than four weeks (29-36 days) 39 40 .

Clinical features such as fever, cough, a sore throat, fatigue, progressive lymphopenia, or neutrophilia, may recur in the immediate future of discharged patients 32 . Fifty-six per cent (56.3%) of discharged patients were shown to still present palpitation, shortness of breath, or dyspnea after physical activity due to the incomplete absorption of the pulmonary opacities.

Corticosteroids were applied again for alleviation of symptoms 41 . However, given the acceptance of remaining fibrous stripes, GGO, or consolidation in the lung, for which absorption could take a broad spectrum of time (see discharge criteria for coronavirus disease), these manifestations were not surprising 18 42 43 .

Another outcome of coronavirus disease that cannot be overlooked is the osteonecrosis. The prevalence of osteonecrosis in patients using corticosteroids was 9.9%, with a total dosage of >1,900 mg hydrocortisone, >2,000 mg methylprednisolone, >13,340 mg hydrocortisoneequivalent corticosteroid therapy, and >18 days on corticosteroid therapy representing significant risk factors for the subsequent development of osteonecrosis 43 . Moreover, the impairment of liver and kidney function required longer time to recover 44 .

During the initial phase of the COVID-19 outbreak in China, 53.8% of respondents rated the psychological impact of the outbreak as moderate or severe; 16.5% reported moderate to severe depressive symptoms; 28.8% reported moderate to severe anxiety symptoms; and 8.1% reported moderate to severe stress levels 45 . Identically, most SARS survivors had favorable physical recovery from their illness, but some patients and their caregivers reported a significant reduction in mental health one year later 46 . Early strategies that aim to prevent and treat traumatization, as well as the psychological burden of an epidemic in medical staff and the general public, are vitally necessary.

One significant mental health concern is post-traumatic stress disorder (PTSD). Inferred from an Impact of Event Scale (IES) Score of N26, the occurrence was 41.7% 47 . In another study in Hong Kong, among 131 survivors, 4% at one month, and 5% at three months post-discharge, experienced symptoms corresponding to PTSD 48 The Follow-up Strategies (Table. 3)

As overcoming the coronavirus pandemic will likely take considerable further global efforts, there will also be a need to emphasize pneumonia follow-up management to prevent potential factors that could reignite viral transmission after discharge. This article is protected by copyright. All rights reserved.

For discharged patients as well as their close contacts, further 14 days of quarantine at home are required 50 . Simultaneously, in order to prevent cross-infection at home, centralized isolations are recommended 16 . Nevertheless, there is a MERS case report showing that a nurse, although kept isolated at home, consistently tested PCR-positive for more than five weeks after the first sampling 51 . This finding should be taken into consideration to update the isolation strategy for some extreme cases.

Several studies have shown an interesting phenomenon, with patients kept under surveillance and quarantined at home after discharge testing positive again from consecutive throat swabs during the follow-up period 33 52 . As the viral load and titer gradually diminish during the convalescent period, patients should remain quarantined and be observed for at least two weeks after discharge, and should be tested for viral nucleic acid again after two weeks of isolation 30 40 51 . Another recommendation suggests that discharged patients should have a throat swab test for SARS-CoV-2 every day or every other day, for at least five times 25 . Sustained viral shedding supports a strategy of isolation of infected but discharged patients, which should be the basis of optimal future antiviral interventions 24 .

Residual lesions were common in chest radiology of coronavirus pneumonia. The host's immune response to coronavirus infection leads to lymphocyte proliferation and macrophage infiltration into alveolar septa and interstitial compartments 53 54 . A significantly greater number of ICU admission days, older age, higher chest radiographic scores, chest radiographic deterioration patterns, and peak lactate dehydrogenase levels, were observed in patients with lung fibrosis 55 . Complete resolution in the chest CT could be observed only at four weeks or longer after the onset of symptoms 22 56 . The radiological manifestation should be tracked until the complete resolution of pulmonary lesions in chest radiographs or CT scanning 57-60 .

In the rehabilitation period, fibrotic changes in the lungs did not resolve in some patients.

These patients complained of a restriction of physical activity from general weakness or shortness of breath due to their decreased pulmonary function, resulting in a lower quality of life 53 54 . A SARS study demonstrated that 25.5% of patients had a pulmonary diffusion abnormalities, with the diffusive capacity of the lung for carbon monoxide being less than 80% 61 . Another study illustrated that one year after recovery from SARS, a persistent impairment of pulmonary function was found in about one third of patients, and the health status of SARS survivors was significantly worse compared to the healthy population (P ﹤ 0.001) based on the St. George Respiratory Questionnaire (SGRQ) 62 .

Magnetic resonance imaging (MRI) for osteonecrosis also has a critical role in follow-up strategies. Individuals who have a risk of avascular necrosis of the femoral head should receive MRI examinations 3 to 6 months after discharge 63 . This article is protected by copyright. All rights reserved.

Based on survey results 44 , a considerable number of SARS patients still experienced psychological issues after discharge from hospital. All patients should be dynamically monitored during admission and before discharge, including the extent of personal mental stress, mood, sleep, stress, and other mental state effects 25 . Moreover, self-assessment tools and assessments by others, including a variety of assessment scales, could be utilized to evaluate the psychologic outcomes of patients (Table. 3) 25 44 47 48 64 .

Likewise, the ability to return to normal activity and work without special care requirements are other items to be considered for evaluation during recovery. Pulmonary function defects commonly lead to a limitation of activities, yet a substantial number of patients experienced a reduced exercise capacity which could not be accounted for by an impairment of pulmonary function 65 . As for the severe coronavirus disease MERS, 84.6% of survivors could return to normal status, whereas the rest were unable to 66 

Telephone follow-up should be carried out at three days, two weeks, three months, and six months after discharge, with outpatient follow-ups at one week, two weeks, and one month after discharge 25 68 .

It should be noted that patients could be regarded as misdiagnosed and would not need to be followed up if two negative serological test results are received at two consecutive follow-ups 63 . Owing to the relative success of COVID-19 containment in China, there are now 81,171 discharged cases under follow-up status 19 . For a comprehensive follow-up process, clinicians were able to imitate and adopt a variety of management policies based on the epidemic history of coronaviruses, comprising SARS and MERS. Notably, SARS uses the same entry receptor (angiotensin-converting enzyme 2, ACE2) as COVID-19, and the pathogenesis, treatment, and the follow-up strategies for COVID-19 could therefore be relatively easily deducted 69 . As viral shedding can potentially be sustained for several weeks, hand hygiene and mask wearing are critical precautionary measures 70 . During the follow-up period, constant hand wiping using a wet towel soaked in water containing 1.00% soap powder, 0.05% active chlorine, or 0.25% active chlorine from sodium hypochlorite and N95 masks, medical masks, and homemade masks made of four-layer kitchen paper and one-layer cloth may supply considerable disease prevention 71 .

By abiding to the follow-up process presented in this review, we expect that management of this outbreak will be achieved soon. Nonetheless, the potency of this outbreak should not be underestimated -COVID-19 remains a significant pandemic, and being discharged from the hospital should not be considered the endpoint of monitoring and precautionary measures. From Accepted Article the time of discharge to long-term follow-up, every aspect of coronavirus management should be readily scrutinized.

Not applicable.

Junhua Zheng and Ke Wu participated in the study design; Zhong Zheng performed data collection and analysis; Zhixian Yao drafted the manuscript; all authors provided critical review of the manuscript and approved the final draft for publication.

The authors declare no conflicts of interest.

The reported work was supported in part by research grants from the National Natural Science Foundation of China (no. 81972393, 81772705, 31570775) .

The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

All analyses were based on previously published studies. Thus, no ethical approval and patient consent are required. Improvements in lesion absorption observed by chest radiography or chest CT scan, including the following items:

(1) reduction of GGO size;

(2) decrease of consolidation density;

(3) only fibrous stripes left. [6, 12, 16, 18, 21, 22, [24] [25] [26] [27] [28] 

(1) Essentially normal body temperature (ear temperature under 37.5℃) for 3 to 7 days or longer;

(2) Normal blood oxygen saturation (>93%) without supplementary oxygen ( 

Corticosteroids completely discontinued for more than 1 [16] Accepted Article (1) Proportion of positive PCR in discharged patients: 3.2~9.1%;

(2) Positive results of PCR in lower respiratory tract ﹤ 2 weeks;

(3) Positive results of PCR in stool or urine ﹤ 4 weeks. [18, 32, 33, 39] 

Manifestations:

(1) Fever;

(2) Cough;

(3) Sore throat;

(4) Fatigue;

(5) Palpitation;

(6) Shortness of breath;

(7) Dyspnea;

(8) Osteonecrosis;

(9) Renal injury;

(10) Hepatic injury. [32, 41, 43, 44] Blood analysis:

(1) Progressive lymphopenia;

This article is protected by copyright. All rights reserved.

(2) Progressive neutrophilia.

(1) GGO;

(2) Consolidation;

(3) Fibrous stripes. [18, 42, 43] Mental Health (1) Depressive symptoms;

(2) Anxiety symptoms;

(3) Stress;

(4) Post-traumatic stress disorder.

[ [45] [46] [47] [48] [49] † PCR = polymerase chain reaction. ‡ GGO = ground-glass opacities. 

(1) Quarantine at home for a 14-day period after discharge;

(2) Centralized isolation or isolation in a hotel is recommended. [16, 50] PCR * PCR should be carried out again after 2week quarantine. [16, 30, 40, 51] Radiology † (1) CT or CXR follow-up until complete absorption of pulmonary lesions.

(2) Patients using corticosteroids should receive an MRI 3 to 6 months after discharge.

[ [57] [58] [59] [60] 63] Pulmonary Function ‡ When visiting the out-patient department, patients should receive pulmonary function tests, including:

(1) FVC; [61, 62] Accepted Article

(2) 2 weeks;

(3) 3 months;

(4) 6 months

Out-patient follow-up (time after discharge):

(1) 1 weeks;

(2) 2 weeks;

(3) 1 months.

* PCR = polymerase chain reaction; † CT = computed tomography; CXR = chest radiography; MRI = magnetic Resonance Imaging; ‡ FVC = forced vital capacity; FEV1 = forced expiratory volume in one second; DLCO = diffusing capacity of the lung for carbon monoxide; SGRQ = St. George Respiratory

Questionnaire.

Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study

WHO. Coronavirus disease 2019 (COVID-19) Situation Report -107. World Health Organization 2020 doi

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment

Clinical infectious diseases: an official publication of the Infectious Diseases Society of America

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19

Effectiveness of glucocorticoid therapy in patients with severe novel coronavirus pneumonia: protocol of a randomized controlled trial

Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study

Understanding the Latest Human Coronavirus Threat

Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease

2019 novel coronavirus of pneumonia in Wuhan, China: emerging attack and management strategies

Cause analysis and treatment strategies of "recurrence" with novel coronavirus pneumonia (covid-19) patients after discharge from hospital

Relapse of SARS upon tapering corticosteroid

Positive RT-PCR Test Results in Patients Recovered From COVID-19

National Health Commision of the People's Republic of China

Diagnosis and treatment of 2019-nCoV pneumonia in China. China National Health Commission Published

Imaging changes in patients with 2019-nCov

Evolution of CT manifestations in a patient recovered from 2019 novel coronavirus (2019-nCoV) pneumonia in Wuhan

First case of Coronavirus Disease 2019 (COVID-19) pneumonia in Taiwan

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Zhejiang da xue xue bao. Yi xue ban

Risk of SARS transmission to persons in close contact with discharged patients

WHO hospital discharge and follow-up policy for patients who have been diagnosed with Severe Acute Respiratory Syndrome (SARS). World Health Organization

Public health measures implemented during the SARS outbreak in Singapore

On Middle East Respiratory Syndrome (MERS) Management In Malaysia. Ministry of Health (Malaysia

Response to Emergence of Middle East Respiratory Syndrome Coronavirus

Diagnosis and treatment scheme for Middle East respiratory syndrome cases (2015 edition). National Health Commision of the People's Republic of China

E6%A1%88%EF%BC%882015%E5%B9%B4%E7%89%88%EF%BC%89+.docx&database=all &siteCode=bm24000006

Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation

Post-discharge surveillance and positive virus detection in two medical staff recovered from coronavirus disease

Euro surveillance: bulletin Europeen sur les maladies transmissibles

Genetic history of hepatitis C virus in Pakistan. Infection

Chest CT for typical 2019-nCoV pneumonia: relationship to negative RT-PCR testing

Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases

Evaluating the accuracy of different respiratory specimens in the laboratory diagnosis and monitoring the viral shedding of 2019-nCoV infections

Chest Radiographic and CT Findings of the 2019 Novel Coronavirus Disease (COVID-19): Analysis of Nine Patients Treated in Korea

Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase. European journal of clinical microbiology & infectious diseases: official publication of the

Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients

Clinical analysis of 190 cases of outbreak with atypical pneumonia in Guangzhou in spring

Thin-section CT in patients with severe acute respiratory syndrome following hospital discharge: preliminary experience

Steroid-induced osteonecrosis in severe acute respiratory syndrome: a retrospective analysis of biochemical markers of bone metabolism and corticosteroid therapy

Diagnosis and treatment of SARS pneumonia in China. China National Health Commission Published

Immediate Psychological Responses and Associated Factors during the Initial Stage of the 2019 Coronavirus Disease (COVID-19) Epidemic among the General Population in China

One-year outcomes and health care utilization in survivors of severe acute respiratory syndrome

Quality of life and psychological status in survivors of severe acute respiratory syndrome at 3 months postdischarge

Posttraumatic stress, anxiety, and depression in survivors of severe acute respiratory syndrome (SARS)

Posttraumatic stress disorder in convalescent severe acute respiratory syndrome patients: a 4-year follow-up study

First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures

A case of longterm excretion and subclinical infection with Middle East respiratory syndrome coronavirus in a healthcare worker

Recurrence of positive SARS-CoV-2 RNA in COVID-19: A case report

How is Type I procollagen synthesis regulated at the gene level during tissue fibrosis

A major outbreak of severe acute respiratory syndrome in Hong Kong

Follow-up chest radiographic findings in patients with MERS-CoV after recovery

Epidemiology and predictors of survival of MERS-CoV infections in Riyadh region

Severe acute respiratory syndrome: radiographic review of 40 probable cases in Toronto

Thin-section CT of severe acute respiratory syndrome: evaluation of 73 patients exposed to or with the disease

Severe acute respiratory syndrome: radiographic appearances and pattern of progression in 138 patients

SARS: imaging of severe acute respiratory syndrome

Follow-up study on pulmonary function and lung radiographic changes in rehabilitating severe acute respiratory syndrome patients after discharge

1-year pulmonary function and health status in survivors of severe acute respiratory syndrome

Dynamic changes of serum SARS-coronavirus IgG, pulmonary function and radiography in patients recovering from SARS after hospital discharge

Posttraumatic stress after SARS

Pulmonary function and exercise capacity in survivors of severe acute respiratory syndrome

The clinical evaluation of chemotherapeutic agents in cancer

Critically ill healthcare workers with the middle east respiratory syndrome (MERS): A multicenter study

An emergency department response to severe acute respiratory syndrome: a prototype response to bioterrorism

Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody. Emerging microbes & infections 2020

Mask-Wearing Behaviors and Its Associated Factors during the COVID-19 Epidemic: A Cross-Sectional Study among Primary School Students in Wuhan

Self-assessment tools:(1) The Self-Reporting Questionnaire 20 items (SRQ-20);(2) The Patient Health Questionnaire-9 (PHQ-9); [ 25, 44, 47, 48, 64, 66, 67] Other-assessment tools:(1) The Hamilton Depression Rating Scale (HAMD);(2) The Hamilton Anxiety Rating Scale (HAMA);(3) The Positive and Negative Syndrome Scale (PANSS).

Remote follow-up (time after discharge):(1) First 3 days; [25, 68]